Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and Their Caregivers
NCT ID: NCT07141407
Last Updated: 2026-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
80 participants
INTERVENTIONAL
2026-04-01
2026-12-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient-centered and Efficacious Advance Care Planning in Cancer: the PEACe Comparative Effectiveness Trial
NCT03824158
Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly
NCT03609177
Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams
NCT07278739
Design and Testing of a Web-Based Tool for the Improvement of End-of-Life Planning in Patients With Advanced Cancer
NCT05564468
Taking Care of Her Program in Patients With Stage III or IV Ovarian Cancer and Spouse Caregivers
NCT02401321
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
ARM I: Participants attend Talking About Cancer (TAC) telephone-based coaching sessions (2 sessions) designed to support participants in communicating about advance care planning (ACP), managing distress around ACP conversations, engaging in the process of ACP, and completing advance directives over 45-60 minutes each once a week (QW) for 2 weeks.
ARM II: Participants receive an ACP brochure/handout on study.
After completion of study intervention, participants are followed up at 6- and 12-weeks post-randomization.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm I (TAC sessions)
Participants attend Talking About Cancer (TAC) telephone-based coaching sessions (2 sessions) designed to support participants in communicating about advance care planning (ACP), managing distress around ACP conversations, engaging in the process of ACP, and completing advance directives over 45-60 minutes each once a week (QW) for 2 weeks.
Supportive Care
Attend TAC telephone-based coaching sessions
Telephone-Based Intervention
Attend TAC telephone-based coaching sessions
Survey Administration
Ancillary studies
Arm II (enhanced usual care)
Participants receive an ACP brochure/handout on study.
Survey Administration
Ancillary studies
Educational Intervention
Receive an ACP brochure/handout
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Supportive Care
Attend TAC telephone-based coaching sessions
Telephone-Based Intervention
Attend TAC telephone-based coaching sessions
Survey Administration
Ancillary studies
Educational Intervention
Receive an ACP brochure/handout
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* PATIENT: Able to provide informed consent
* PATIENT: Fluent in English or Spanish
* PATIENT: Have access to a telephone or computer with internet access
* CAREGIVER: Person patient indicates provides support
* CAREGIVER: English or Spanish speaking
* CAREGIVER: 18 years of age or older
* CAREGIVER: Able to provide informed consent
Exclusion Criteria
* PATIENT: Receiving hospice at the time of enrollment
* PATIENT: Younger than age 18
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fred Hutchinson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Megan Shen, PhD
Role: PRINCIPAL_INVESTIGATOR
Fred Hutch/University of Washington Cancer Consortium
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RG1125666
Identifier Type: -
Identifier Source: org_study_id
NCI-2025-05520
Identifier Type: REGISTRY
Identifier Source: secondary_id
FHIRB0020936
Identifier Type: OTHER
Identifier Source: secondary_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.